Post-receptor IGF1 insensitivity restricted to the MAPK pathway in a Silver-Russell syndrome patient with hypomethylation at the imprinting control region on chromosome 11

European Journal of Endocrinology

Volumn 166, Issue 3, 2012, Pages 543-550

  Montenegro, Luciana R ^a   Leal, Andrea C ^a   Coutinho, Debora C ^a   Valassi, Helena P L ^a   Nishi, Mirian Y ^a   Arnhold, Ivo J P ^a   Mendonca, Berenice B ^a   Jorge, Alexander A L ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; PROTEIN KINASE B; RECOMBINANT GROWTH HORMONE; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ADOLESCENT; ARTICLE; CASE REPORT; CELL PROLIFERATION; CHROMOSOME 11; CHROMOSOME STRUCTURE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DISEASE SEVERITY; DNA METHYLATION; DUSP4 GENE; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; FIBROBLAST CULTURE; GENE; GENE CONTROL; GENE EXPRESSION REGULATION; GENOME IMPRINTING; GROWTH DISORDER; GROWTH RATE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; INSULIN LIKE GROWTH FACTOR 1 GENE; INSULIN LIKE GROWTH FACTOR RECEPTOR TYPE 1 GENE; MALE; MEF2C GENE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SILVER RUSSELL SYNDROME;

CELLS, CULTURED; CHILD; CHROMOSOMES, HUMAN, PAIR 11; DNA METHYLATION; GENOMIC IMPRINTING; HUMANS; INSULIN-LIKE GROWTH FACTOR I; MALE; MAP KINASE SIGNALING SYSTEM; RECEPTOR, IGF TYPE 1; SILVER-RUSSELL SYNDROME;

EID: 84857952205     PISSN: 08044643     EISSN: 1479683X     Source Type: Journal    
DOI: 10.1530/EJE-11-0964     Document Type: Article

References (21)

1. Abu-Amero S, Monk D, Frost J, Preece M, Stanier P & Moore GE. The genetic aetiology of Silver-Russell syndrome. Journal of Medical Genetics 2008 45 193-199. (doi:10.1136/jmg.2007.053017)
2. Binder G, Seidel AK, Martin DD, Schweizer R, Schwarze CP, Wollmann HA, Eggermann T & Ranke MB. The endocrine phenotype in Silver-Russell syndrome is defined by the underlying epigenetic alteration. Journal of Clinical Endocrinology and Metabolism 2008 93 1402-1407. (doi:10.1210/jc.2007-1897)
3. Kotzot D. Maternal uniparental disomy 7 and Silver-Russell syndrome - clinical update and comparison with other subgroups. European Journal of Medical Genetics 2008 51 444-451. (doi:10.1016/j.ejmg.2008.06.001)
4. Gicquel C, Rossignol S, Cabrol S, Houang M, Steunou V, Barbu V, Danton F, Thibaud N, Le Merrer M, Burglen L, Bertrand AM, Netchine I & Le Bouc Y. Epimutation of the telomeric imprinting center region on chromosome 11p15 in Silver-Russell syndrome. Nature Genetics 2005 37 1003-1007. (doi:10.1038/ng1629)
5. Netchine I, Rossignol S, Dufourg MN, Azzi S, Rousseau A, Perin L, Houang M, Steunou V, Esteva B, Thibaud N, Demay MC, Danton F, Petriczko E, Bertrand AM, Heinrichs C, Carel JC, Loeuille GA, Pinto G, Jacquemont ML, Gicquel C, Cabrol S & Le Bouc Y. 11p15 imprinting center region 1 loss of methylation is a common and specific cause of typical Silver-Russell syndrome: clinical scoring system and epigenetic-phenotypic correlations. Journal of Clinical Endocrinology and Metabolism 2007 92 3148-3154. (doi:10.1210/jc.2007-0354)
6. Firth SM & Baxter RC. Cellular actions of the insulin-like growth factor binding proteins. Endocrine Reviews 2002 23 824-854. (doi:10.1210/er. 2001-0033)
7. Modric T, Silha JV, Shi Z, Gui Y, Suwanichkul A, Durham SK, Powell DR & Murphy LJ. Phenotypic manifestations of insulin-like growth factor-binding protein-3 overexpression in transgenic mice. Endocrinology 2001 142 1958-1967. (doi:10.1210/en.142.5.1958)
8. Bartholdi D, Krajewska-Walasek M, Ounap K, Gaspar H, Chrzanowska KH, Ilyana H, Kayserili H, Lurie IW, Schinzel A &Baumer A. Epigenetic mutations of the imprinted IGF2-H19 domain in Silver-Russell syndrome (SRS): results from a large cohort of patients with SRS and SRS-like phenotypes. Journal of Medical Genetics 2009 46 192-197. ( doi:10.1136/jmg.2008.061820)
9. Silva EG, Slhessarenko N, Arnhold IJ, Batista MC, Estefan V, Osorio MG, Marui S & Mendonca BB. GH values after clonidine stimulation measured by immunofluorometric assay in normal prepubertal children and GH-deficient patients. Hormone Research 2003 59 229-233. ( doi:10.1159/000070222)
10. Coutinho DC, Coletta RR, Costa EM, Pachi PR, Boguszewski MC, Damiani D, Mendonca BB, Arnhold IJ & Jorge AA. Polymorphisms identified in the upstream core polyadenylation signal of IGF1 gene exon 6 do not cause pre- and postnatal growth impairment. Journal of Clinical Endocrinology and Metabolism 2007 92 4889-4892. (doi:10.1210/jc.2007-1661)
11. Eggermann T, Schonherr N, Eggermann K, Buiting K, Ranke MB, Wollmann HA & Binder G. Use of multiplex ligation-dependent probe amplification increases the detection rate for 11p15 epigenetic alterations in Silver-Russell syndrome. Clinical Genetics 2008 73 79-84. (doi:10.1111/j.1399-0004.2007.00930. x)
12. Coelho JC & Giugliani R. Fibroblasts of skin fragments as a tool for the investigation of genetic diseases: technical recommendations. Genetics and Molecular Biology 2000 23 269-271. ( doi:10.1590/S1415-47572000000200004)
13. Tada H, Shiho O, Kuroshima K, Koyama M & Tsukamoto K. An improved colorimetric assay for interleukin 2. Journal of Immunological Methods 1986 93 157-165. (doi:10.1016/0022-1759(86)90183-3)
14. Chomczynski P & Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Analytical Biochemistry 1987 162 156-159. ( doi:10.1016/0003-2697(87)90021-2)
15. Livak KJ & Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(KDelta Delta C(T)) method. Methods 2001 25 402-408. (doi:10.1006/meth.2001.1262)
16. Francis GL, Ross M, Ballard FJ, Milner SJ, Senn C, McNeil KA, Wallace JC, King R & Wells JR. Novel recombinant fusion protein analogues of insulin-like growth factor (IGF)-I indicate the relative importance of IGF-binding protein and receptor binding for enhanced biological potency. Journal of Molecular Endocrinology 1992 8 213-223. ( doi:10.1677/jme.0.0080213)
17. Abuzzahab MJ, Schneider A, Goddard A, Grigorescu F, Lautier C, Keller E, KiessW, Klammt J, Kratzsch J, Osgood D, Pfaffle R, Raile K, Seidel B, Smith RJ & Chernausek SD. IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. New England Journal of Medicine 2003 349 2211-2222. (doi:10.1056/NEJMoa010107)
18. Munoz JP, Collao A, Chiong M, Maldonado C, Adasme T, Carrasco L, Ocaranza P, Bravo R, Gonzalez L, Diaz-Araya G, Hidalgo C & Lavandero S. The transcription factor MEF2C mediates cardiomyocyte hypertrophy induced by IGF-1 signaling. Biochemical and Biophysical Research Communications 2009 388 155-160. (doi:10.1016/j.bbrc.2009.07.147)
19. Patterson KI, Brummer T, O'Brien PM & Daly RJ. Dual-specificity phosphatases: critical regulators with diverse cellular targets. Biochemical Journal 2009 418 475-489. (doi:10.1042/BJ20082234)
20. Waha A, Felsberg J, Hartmann W, von dem Knesebeck A, Mikeska T, Joos S, Wolter M, Koch A, Yan PS, Endl E, Wiestler OD, Reifenberger G & Pietsch T. Epigenetic downregulation of mitogen-activated protein kinase phosphatase MKP-2 relieves its growth suppressive activity in glioma cells. Cancer Research 2010 70 1689-1699. (doi:10.1158/0008-5472.CAN-09-3218)
21. Turner CL, Mackay DM, Callaway JL, Docherty LE, Poole RL, Bullman H, Lever M, Castle BM, Kivuva EC, Turnpenny PD, Mehta SG, Mansour S, Wakeling EL, Mathew V, Madden J, Davies JH & Temple IK. Methylation analysis of 79 patients with growth restriction reveals novel patterns of methylation change at imprinted loci. European Journal of Human Genetics 2010 18 648-655. (doi:10.1038/ejhg.2009.246)